This Medical Device Stock Is Down 25%. One Fund Just Disclosed Buying $5 Million More

6 hours ago 2

Jonathan Ponciano, The Motley Fool

Sat, May 16, 2026 astatine 12:19 PM CDT 4 min read

Sea Cliff Partners Management disclosed a acquisition of 55,359 Integer Holdings (NYSE:ITGR) shares successful its May 15, 2026, SEC filing, an estimated $4.71 cardinal commercialized based connected quarterly mean pricing.

What happened

According to its SEC filing dated May 15, 2026, Sea Cliff Partners Management accrued its presumption successful Integer Holdings (NYSE:ITGR) by 55,359 shares during the archetypal quarter. The estimated worth of this commercialized was $4.71 million, based connected the quarter’s mean stock price. The quarter-end presumption was worthy $16.57 million. The nett presumption change, including marketplace movement, was $6.14 cardinal higher than the anterior quarter.

What other to cognize

This was a buy; Integer Holdings present accounts for 8.56% of the fund’s 13F assets nether management.
Top 5 holdings post-filing:
- NASDAQ: BTSG: $33.43 cardinal (17.3% of AUM)
- NYSE: WCC: $23.59 cardinal (12.2% of AUM)
- NYSE: LTH: $17.70 cardinal (9.1% of AUM)
- NASDAQ: OKTA: $17.32 cardinal (8.9% of AUM)
- NYSE: ITGR: $16.57 cardinal (8.6% of AUM)
As of May 14, 2026, ITGR shares were priced astatine $89.82, down 25% implicit the past twelvemonth and lagging the S&P 500 by implicit 50 percent points.

Company Overview

Metric

Value

Revenue (TTM)	$1.85 billion
Net Income (TTM)	$141.80 million
Market Capitalization	$3 billion
Price (as of marketplace adjacent 2026-05-14)	$89.82

Company Snapshot

Integer Holdings produces a divers scope of aesculapian devices and components, including products for interventional cardiology, cardiac bushed management, neuromodulation, orthopedic surgery, and surgical instruments.
The steadfast operates arsenic a declaration manufacturer, generating gross by designing, developing, and manufacturing devices and sub-assemblies for archetypal instrumentality manufacturers successful the healthcare sector.
It serves multinational OEMs and their subsidiaries successful cardiac, neuromodulation, orthopedics, vascular, and precocious surgical markets, with a planetary lawsuit base.

Integer Holdings is simply a starring aesculapian instrumentality outsource shaper with a wide portfolio serving the planetary healthcare industry. The institution leverages precocious manufacturing capabilities and heavy engineering expertise to present high-quality products for analyzable aesculapian applications. Its scale, method know-how, and diversified lawsuit relationships underpin a competitory presumption successful the aesculapian instrumentality proviso chain.

What this transaction means for investors

This bargain yet looks similar a calculated stake that Integer Holdings’ caller weakness whitethorn person created an accidental up of a perchance transformative infinitesimal for the company. While the acquisition happened earlier absorption announced a strategical reappraisal connected April 30, the timing is inactive notable fixed the committee aboriginal said it would research options including a sale, merger, oregon different strategical combination.

The marketplace had already been souring connected Integer earlier that announcement. Shares were down 25% implicit the past twelvemonth arsenic investors disquieted astir slowing maturation and impermanent headwinds tied to respective caller products. First-quarter results reflected immoderate of that pressure. Sales roseate conscionable 0.5% to $440 million, portion adjusted operating income fell 14% to $61 million. Management besides lowered parts of its 2026 outlook and flagged lawsuit forecast changes and broader marketplace dynamics.

For semipermanent investors, the communicative present hinges connected whether operational maturation reaccelerates successful 2027 arsenic absorption said it expects, oregon whether the strategical reappraisal unlocks worth sooner done a transaction.

Read Entire Article